These results, together with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 help the strategy of focusing on ACKR3 as a novel solution to modulate the opioid process, which could open new therapeutic avenues for opioid-associated Problems. A exploration examine released in https://malcolmj840qhy5.wikigop.com/user